337 related articles for article (PubMed ID: 15465973)
1. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.
Petrakis IL; Limoncelli D; Gueorguieva R; Jatlow P; Boutros NN; Trevisan L; Gelernter J; Krystal JH
Am J Psychiatry; 2004 Oct; 161(10):1776-82. PubMed ID: 15465973
[TBL] [Abstract][Full Text] [Related]
2. Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients.
Krystal JH; Petrakis IL; Limoncelli D; Webb E; Gueorgueva R; D'Souza DC; Boutros NN; Trevisan L; Charney DS
Neuropsychopharmacology; 2003 Nov; 28(11):2020-8. PubMed ID: 12888778
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism.
Krystal JH; Madonick S; Perry E; Gueorguieva R; Brush L; Wray Y; Belger A; D'Souza DC
Neuropsychopharmacology; 2006 Aug; 31(8):1793-800. PubMed ID: 16395307
[TBL] [Abstract][Full Text] [Related]
4. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics.
Krystal JH; Petrakis IL; Webb E; Cooney NL; Karper LP; Namanworth S; Stetson P; Trevisan LA; Charney DS
Arch Gen Psychiatry; 1998 Apr; 55(4):354-60. PubMed ID: 9554431
[TBL] [Abstract][Full Text] [Related]
5. NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy.
Krystal JH; Petrakis IL; Krupitsky E; Schutz C; Trevisan L; D'Souza DC
Ann N Y Acad Sci; 2003 Nov; 1003():176-84. PubMed ID: 14684445
[TBL] [Abstract][Full Text] [Related]
6. Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist.
Phelps LE; Brutsche N; Moral JR; Luckenbaugh DA; Manji HK; Zarate CA
Biol Psychiatry; 2009 Jan; 65(2):181-4. PubMed ID: 18996507
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists.
Krupitsky EM; Burakov AM; Romanova TN; Grinenko NI; Grinenko AY; Fletcher J; Petrakis IL; Krystal JH
Neuropsychopharmacology; 2001 Dec; 25(6):936-47. PubMed ID: 11750186
[TBL] [Abstract][Full Text] [Related]
9. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
[TBL] [Abstract][Full Text] [Related]
10. Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.
Luckenbaugh DA; Ibrahim L; Brutsche N; Franco-Chaves J; Mathews D; Marquardt CA; Cassarly C; Zarate CA
Bipolar Disord; 2012 Dec; 14(8):880-7. PubMed ID: 22978511
[TBL] [Abstract][Full Text] [Related]
11. Ethanol-like effects of thiopental and ketamine in healthy humans.
Dickerson D; Pittman B; Ralevski E; Perrino A; Limoncelli D; Edgecombe J; Acampora G; Krystal JH; Petrakis I
J Psychopharmacol; 2010 Feb; 24(2):203-11. PubMed ID: 19028835
[TBL] [Abstract][Full Text] [Related]
12. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
[TBL] [Abstract][Full Text] [Related]
13. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
Krystal JH; Abi-Saab W; Perry E; D'Souza DC; Liu N; Gueorguieva R; McDougall L; Hunsberger T; Belger A; Levine L; Breier A
Psychopharmacology (Berl); 2005 Apr; 179(1):303-9. PubMed ID: 15309376
[TBL] [Abstract][Full Text] [Related]
14. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.
Krystal JH; Perry EB; Gueorguieva R; Belger A; Madonick SH; Abi-Dargham A; Cooper TB; Macdougall L; Abi-Saab W; D'Souza DC
Arch Gen Psychiatry; 2005 Sep; 62(9):985-94. PubMed ID: 16143730
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate CA; Singh JB; Carlson PJ; Brutsche NE; Ameli R; Luckenbaugh DA; Charney DS; Manji HK
Arch Gen Psychiatry; 2006 Aug; 63(8):856-64. PubMed ID: 16894061
[TBL] [Abstract][Full Text] [Related]
16. N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability.
Krystal JH; Petrakis IL; Mason G; Trevisan L; D'Souza DC
Pharmacol Ther; 2003 Jul; 99(1):79-94. PubMed ID: 12804700
[TBL] [Abstract][Full Text] [Related]
17. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers.
Parwani A; Weiler MA; Blaxton TA; Warfel D; Hardin M; Frey K; Lahti AC
Psychopharmacology (Berl); 2005 Dec; 183(3):265-74. PubMed ID: 16220331
[TBL] [Abstract][Full Text] [Related]
18. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
[TBL] [Abstract][Full Text] [Related]
20. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
